scispace - formally typeset
B

Bingfang Yan

Researcher at University of Rhode Island

Publications -  72
Citations -  3968

Bingfang Yan is an academic researcher from University of Rhode Island. The author has contributed to research in topics: Pregnane X receptor & Transactivation. The author has an hindex of 32, co-authored 63 publications receiving 3548 citations.

Papers
More filters
Journal ArticleDOI

Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles

TL;DR: The design of a near-infrared light-induced transformative nanoparticle platform that combines photothermal ablation with immunotherapy and is more effective than either immunotherapy or photothermal therapy alone against primary treated and distant untreated tumors in a mouse breast cancer model is reported.
Journal ArticleDOI

Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel

TL;DR: Con concurrent use of both drugs would inhibit the activation of oseltamivir, thus making this antiviral agent therapeutically inactive, which is epidemiologically of significance because people who receive osel Tamsivir and clopidogrel simultaneously may maintain susceptibility to influenza infection or a source of spreading influenza virus if already infected.
Journal ArticleDOI

A Comparative Study of Hollow Copper Sulfide Nanoparticles and Hollow Gold Nanospheres on Degradability and Toxicity

TL;DR: Comparison of hollow CuS nanoparticles with hollow gold nanospheres in similar particle sizes and morphology following intravenous administration to mice will advance the development of HCuSNPs as a new class of biodegradable inorganic nanomaterials for photothermal therapy.
Journal ArticleDOI

Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol

TL;DR: The isoform-specific hydrolysis of aspirin and clopidogrel suggests that these two antithrombogenic agents may have pharmacokinetic interactions with different sets of ester drugs, and the altered Hydrolysis by polymorphic mutants provides a molecular explanation to the interindividual variation.
Journal ArticleDOI

Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.

TL;DR: CYP2B6 is highly inducible by known CYP3A4 inducers and hPXR is a major determinant of CYP2B 6-inducible expression for many, but not all, compounds evaluated in this study.